VitaLink Research Adopts Clinical Research IO eSource, eRegulatory and CTMS System

CAMBRIDGE, Mass., May 19, 2020 /PRNewswire/ — VitaLink Research, a leading multi-therapeutic clinical trial network, has adopted the leading, fully-integrated eSource, eRegulatory and Clinical Trial Management System (CTMS) from Clinical Research IO (CRIO). VitaLink Research will use the system to collect clinical trial data electronically, enabling the sponsors and CROs they partner with to perform remote monitoring with ease, while increasing their own network’s ability to work efficiently and seamlessly across multiple site locations.

“VitaLink has always looked at how to work smarter…not harder.  With today’s challenging world, we feel that the CRIO platform will allow better access to live study data,” said Steve Clemons, VitaLink Research’s Founder and Chief Executive Officer. “Adopting ePlatforms in the industry will not only allow better patient care, but will also provide several synergies for partner CRO and Sponsor organizations.”

“We especially liked CRIO’s user-friendly interface which allows our QA/QC departments to remotely and rapidly perform full source to CRF review,” said Haley Williams, VitaLink Research’s Vice President of Quality. “Which further allows us to continue working smarter…not harder.”

“We’re delighted to welcome VitaLink Research into our community of users,” said Raymond Nomizu, CRIO’s CEO. “They are a high performing, fast growing site network, and we look forward to partnering with them as they grow and evolve their business.”

VitaLink Research plans to initiate CRIO’s eSource and eRegulatory system on all new studies, and migrate their patient and financial data to CRIO’s CTMS module.

VitaLink Research is a FULLY INTEGRATED NETWORK OF CLINICAL TRIAL SITES connecting world renowned physicians and medical professionals with site managers and research staff to create a seamless trial experience that puts the patient first and produces trustworthy, consistent results and high quality results.

Clinical Research IO is a comprehensive, Part 11 compliant technology platform for clinical research sites, with eSource, CTMS, and eRegulatory solutions. Since its launch in September 2016, over 500 research sites in 10 countries have adopted the system.

Media Contact: Raymond Nomizu, CEO
Email: 239963@email4pr.com
Address: 1 Main Street, Suite 150
Cambridge, MA 02142
Phone: (617) 302-9845

View original content to download multimedia:http://www.prnewswire.com/news-releases/vitalink-research-adopts-clinical-research-io-esource-eregulatory-and-ctms-system-301061409.html

SOURCE Clinical Research IO

Staff

Recent Posts

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

15 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

15 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

15 hours ago